Menu
Start Screening

Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

Physical Sciences Anxiety or worry Environmental research

1 paper

Anxiety or worry

Based on 41 papers

Researchers are finding several promising ways to reduce anxiety and worry. The strongest and most consistent clinical results so far come from giving psychedelic or fast‑acting drugs together with careful psychotherapy. Ketamine, MDMA, and psilocybin show the quickest and clearest positive results in trials for related problems. Non‑drug approaches like talking therapies and physical activity also help and have longer histories of evidence. At the same time, many drug studies are still small, early‑stage, or done in narrowly selected groups. Important factors that shape outcomes include how the drug is given, the therapy around it, and safety monitoring. There are real risks and unanswered questions, so scientists say more large, diverse, and carefully run trials are needed before these treatments become routine.

Key findings

  • Giving psychedelic drugs together with structured psychotherapy has produced positive results in clinical trials, especially for hard‑to‑treat depression and for PTSD when MDMA is used with therapy. 15063 15086 15053 15085
  • Clinical trials testing psychedelics specifically for people diagnosed with anxiety disorders are fewer and smaller, but a review of nine trials reported reductions in anxiety for several drugs (ketamine, LSD, MDMA, psilocybin, ayahuasca). This evidence is promising but still limited. 15068 15053
  • Ketamine can reduce depressive and anxiety‑like symptoms quickly. Animal and cell studies show low ketamine doses change glutamate receptors and boost fast synaptic activity, which likely helps its rapid effects in people. 10148 15068 15091
  • Non‑drug treatments also have solid evidence. High‑quality reviews find psychodynamic psychotherapy helps some anxiety problems, and walking and other physical activity produce medium‑sized drops in anxiety symptoms in randomized trials. 13302 8785 8792
  • How a psychedelic session is prepared and run matters a lot. Reviews and treatment guides agree that screening, preparing a person’s mindset, the physical setting, and follow‑up therapy are commonly used and considered important for safety and benefit. 15065 15086 15063 15092
  • Psychedelics appear to change the brain by increasing plasticity (the brain’s ability to form new connections) and by lowering inflammation in some studies, but human evidence for measurable blood markers (like BDNF) is mixed and not conclusive. 15132 15050 15091 15129
  • There are safety concerns and limits to generalizing results. Serious risks have been linked to some compounds (for example ibogaine can have cardiac risks), long‑lasting perceptual problems have been reported after hallucinogen use, and many trials include few people of color. 15085 15080 15048 15095
  • Many clinical trials are early‑stage or small. No psychedelic medicine is yet widely approved for anxiety disorders, and researchers call for larger, well‑controlled, and more diverse studies before changing standard care. 15078 15056 15095

Green space exposure on depression and anxiety outcomes: A meta-analysis

Ziquan Liu, Xuemei Chen, Huanhuan Cui, Yuxuan Ma, Ning Gao, Xinyu Li, et al.
PubMed Summary & key facts 2023 118 citations

This meta-analysis of observational studies found that higher exposure to green space was linked with slightly lower odds of depression and possibly lower odds of anxiety. A 10% increase in the amount of green space was associated with lower odds of depression (OR 0.963; 95% CI 0.948–0.979) and with a…

Land Use and Ecosystem Services Urban Agriculture and Sustainability Urban Green Space and Health
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.